SightfileU.S. market data from official filings
Companies › SVA
SINOVAC BIOTECH LTD (SVA)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001084201 · EDGAR filings · Updated 2026-07-15
SINOVAC BIOTECH LTD (SVA) has reported institutional ownership of 14.6%, with 29 institutional managers holding positions valued at $224.9M per the latest 13F reporting period.
Institutional ownership
14.6%
Institutional managers
29
Reported 13F value
$224.9M
Latest updates
- 2026-07-15 — Foreign issuer report (6-K) filed
- 2026-06-15 — Foreign issuer report (6-K) filed
- 2026-06-05 — Foreign issuer report (6-K) filed
- 2026-06-05 — Annual report (20-F) filed
- 2026-05-29 — Foreign issuer report (6-K) filed
- 2026-05-21 — Foreign issuer report (6-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, SINOVAC BIOTECH LTD has 29 institutional holders and institutional ownership of 14.6%.
Insider activity
Insiders reported 0 transactions (0 buys, 0 sells) across 9 reporting insiders, with a net reported value of $0.
Related companies
OPKO HEALTH INC (OPK) · VIEMED HEALTHCARE INC (VMD) · CABALETTA BIO INC (CABA) · C4 THERAPEUTICS INC (CCCC) · CLIMB BIO INC (CLYM) · ALTIMMUNE INC (ALT)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-15.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-15.